Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cloud

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Neurology|March 15, 2021
COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical RegistryDominique A Cadilhac, Joosup Kim, Emma K Tod, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Healthcare (Basel, Switzerland)|December 8, 2023
A Network of Sites and Upskilled Therapists to Deliver Best-Practice Stroke Rehabilitation of the Arm: Protocol for a Knowledge Translation StudyLeeanne M Carey, Liana S Cahill, Jannette M Blennerhassett, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
European Heart Journal|August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trialRory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
The Lancet. Neurology|October 31, 2020
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trialAtte Meretoja, Nawaf Yassi, Teddy Y Wu, et al.
Stroke and Vascular Neurology|December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA Neurology|January 23, 2019
Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical TrialsRomain Bourcier, Mayank Goyal, David S Liebeskind, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Neurology|March 15, 2021
COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical RegistryDominique A Cadilhac, Joosup Kim, Emma K Tod, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Healthcare (Basel, Switzerland)|December 8, 2023
A Network of Sites and Upskilled Therapists to Deliver Best-Practice Stroke Rehabilitation of the Arm: Protocol for a Knowledge Translation StudyLeeanne M Carey, Liana S Cahill, Jannette M Blennerhassett, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
European Heart Journal|August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trialRory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
The Lancet. Neurology|October 31, 2020
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trialAtte Meretoja, Nawaf Yassi, Teddy Y Wu, et al.
Stroke and Vascular Neurology|December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA Neurology|January 23, 2019
Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical TrialsRomain Bourcier, Mayank Goyal, David S Liebeskind, et al.
Pageof 8